相关实验视频

Updated: May 26, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

六个事件影响了瘤学中的抗体批准

Suman Paul^1,2, Shibin Zhou^1,2

¹Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, United States.

Frontiers in immunology

|February 25, 2025

概括

在过去的25年里,治疗性抗体改变了癌症治疗. 六个关键事件,包括抗体-药物合物和免疫检查点抑制剂,导致了快速批准和改进的精确瘤学.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

25年前批准Rituximab标志着抗癌疗法的转折点.
近年来,抗体批准的波动加快,包括抗体-药物联合体 (ADC) 和双特异性抗体 (BsAbs).

研究的目的:

分析过去25年来塑造了瘤学治疗抗体的开发和批准的六个关键事件.
提供关于基于抗体的癌症治疗的演变的见解.

主要方法:

标志性抗体在瘤学中的批准的历史审查.
检查关键抗体格式的发展:ADCs,BsAbs和免疫检查点抑制剂.
欧洲药品管理局 (EMA) 和食品和药物管理局 (FDA) 对监管里程碑的分析.

主要成果:

利图西马布和特拉斯图祖马布的批准确立了针对血液和固体瘤的抗体.
开发ADCs和BsAbs显著增强了向的癌细胞杀伤.
伊皮利穆马布的批准引入了免疫检查点抑制,扩大了基于遗传标记的免疫治疗应用.

结论:

由技术进步和关键发现驱动的抗体疗法的进化,已经彻底改变了癌症治疗.
了解这些历史里程碑对于准确瘤学的未来抗体开发至关重要.

关键词:

抗体是一种抗体.抗体药物合物 (ADC) 的使用双特异抗体 (bsAb) 是指两种特定的抗体.免疫检查点抑制剂免疫检查点抑制剂瘤学在瘤学方面.

更多相关视频

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.